在非恶性子宫疾病中,GLP-1受体激活剂加上孕激素和子宫内膜癌风险
Ting-Tai Yen1, Tina Yi Jin Hsieh2, Gin-Yi Lee3
1Department of Obstetrics and Gynecology, Texas Tech University Health Sciences Center El Paso, El Paso.
JAMA network open
|February 10, 2026
概括
将葡萄糖类-1受体激动剂 (GLP-1RAs) 与孕激素结合使用,可显著降低患有良性子宫疾病的女性子宫内膜癌 (EC) 风险. 这种组合疗法还降低了随后的子宫切除率,为激素和代谢风险管理提供了有希望的策略.
科学领域:
- 妇科 妇科 妇科 妇科
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
背景情况:
- 子宫内膜癌 (EC) 的发病率正在增加,特别是在肥胖和代谢障碍的人群中.
- 需要有效的策略来管理与EC相关的荷尔蒙和代谢风险.
- 子宫内膜增生 (EH) 和良性子宫病理是需要治疗的常见疾病.
研究的目的:
- 为了评估使用孕激素治疗的患有EH或良性子宫病理的患者的EC风险,与接受结合孕激素和葡萄糖类-1受体激活剂 (GLP-1RAs) 患者相比.
主要方法:
- 一项利用TriNetX平台的队列研究分析了2005年5月至2022年12月期间被诊断患有EH或良性子宫病理的成年妇女的非身份电子健康记录.
- 该研究比较了四个治疗组的EC发病率和子宫切除率:GLP-1RA加孕激素与仅孕激素;GLP-1RA加孕激素与甲素加孕激素;三重治疗 (GLP-1RA,甲素,孕激素) 与甲素加孕激素;三重治疗与仅孕激素.
- 亚组根据孕激素路线,风险水平,BMI和年龄对分层患者进行分析,以评估研究结果的一致性.
主要成果:
- 总共有18414名患者接受了GLP-1RA与孕激素,426,406人仅接受了孕激素.
- 结合GLP-1RA和孕激素治疗与与孕激素单独治疗相比显著降低了EC风险 (HR,0.34;95% CI,0.27-0.44),在各小组中发现一致.
- 此外,GLP-1RA加孕激素的EC风险低于甲胺加孕激素 (HR,0.30;95% CI,0.15-0.59),三重疗法比双重或孕激素单一疗法更有效.
- 在GLP-1RA加孕激素组的子宫切除率在2年 (HR,0.47;95%CI,0.42-0.53) 和5年 (HR,0.59;95%CI,0.54-0.64) 随访期间都较低.
结论:
- 在这组患有良性子宫病理或EH的女性中,GLP-1RAs和孕激素的组合与子宫内膜癌的风险降低有关.
- 这些发现表明,这种组合治疗可能是管理该患者群体中EC风险的有价值策略.
- 需要进一步的研究来探索这种保护性关联的临床适用性和潜在机制.
相关概念视频
Glucagon-like Receptor Agonists
1.0K
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.0K
Drug-Receptor Interaction: Agonist
4.2K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.2K
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
1.0K
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
1.0K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
524
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
524
Uterine Tubes
2.5K
The uterine or fallopian tubes function as the conduit through which oocytes travel from the ovaries to the uterus. Each fallopian tube measures approximately 10 to 13 cm long and is anatomically divided into the infundibulum, ampulla, isthmus, and interstitial part (or intramural segment). The infundibulum is characterized by its funnel shape and features extensions called fimbriae which reach towards the peritoneal cavity. These fimbriae play a critical role during ovulation as they extend...
2.5K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
641
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
641


